Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | IDH2 | P48735 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2066345 | 0.83 | HSD17B10 (0.38) | IDH1IDH2HSD17B10 | |
| SCHEMBL17813511 | 0.75 | IDH1 (0.40) | IDH1IDH2KDM4EALDH1A1HPGD | |
| SCHEMBL3516220 | 0.75 | GSK3A (0.33) | IDH1 | |
| SCHEMBL8629038 | 0.75 | CYP11B2 (0.36) | IDH1MEN1KMT2AHTR1ADRD2 | |
| SCHEMBL17813510 | 0.74 | PDE3B (0.33) | — | |
| SCHEMBL46315 | 0.73 | CYP11B2 (0.50) | CYP1A2HTR1ADRD2HTR2A | |
| SCHEMBL2067594 | 0.72 | ADRA2A (0.36) | CYP1A2CYP2C9HTR1AHTR2A | |
| SCHEMBL31411118 | 0.72 | ADRA2A (0.36) | CYP1A2CYP2C9HTR1AHTR2A | |
| SCHEMBL2067239 | 0.71 | IDH1 (0.31) | IDH1 | |
| SCHEMBL18168056 | 0.71 | IDH1 (0.43) | IDH1IDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011151436-A2 | NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | disclosed |